Nested Therapeutics News Today

Concurrent publication in the journal Cancer Discovery highlights NST-628s differentiated mechanism and preclinical activity across diverse KRAS-, NRAS-, and BRAF-driven tumors

/PRNewswire/ -- Nested Therapeutics, a biotechnology company pioneering a next-generation precision medicine platform to address hard-to-treat cancers, today...

The Goldman Sachs Group Inc's (NYSE: GS) Goldman Sachs Asset Management recently 

Goldman Sachs Asset Management said on Wednesday it had raised $650 million for a new fund that will invest in startups related to the life sciences sector. The fund, West Street Life...

Goldman Sachs’s new fund—its first dedicated to life sciences—will focus on early- to mid-stage therapeutics companies with multiple assets. Genetic medicine, cell therapy, immunotherapy, and artificial intelligence are among the areas of investment interest for the firm.

The closing finished well above its original target and represents one of the largest first-time private life sciences growth funds.

BioPharma

(Reuters) - Goldman Sachs Asset Management said on Wednesday it had raised $650 million for a new fund that will invest in startups related to the lif...

/PRNewswire/ -- Nested Therapeutics, a biotechnology company pioneering a next-generation precision medicine platform to address hard-to-treat cancers, today...

/PRNewswire/ -- Shanghai Stock Exchange listed company HitGen Inc. ("HitGen", SSE: 688222.SH) today announced that it has entered into a research service...